NONMEM Users Network Archive

Hosted by Cognigen

Free speed consulting with Pharmetheus at PAGE in Stockholm

From: Martin Bergstrand <martin.bergstrand>
Date: Tue, 21 May 2019 10:36:31 +0200

Free speed consulting with Pharmetheus at PAGE in Stockholm

Due to its popularity last year, Pharmetheus will again offer free speed
consulting at the PAGE Meeting in Stockholm, Sweden. Pharmetheus will
offer professional pharmacometric consulting sessions (~30 min), =
free of
charge. Note that these sessions are open to everyone and independent =
any current or future plans to use our services.
Pharmetheus’ senior experts are available to give input o=
n a wide range of
pharmacometric topics, offering strategic as well as hands-on assistan=
concerning small as well as large molecules and drug projects in =
development phases. Examples of topics below (not limited to):

- Study/experimental design (e.g. optimal design, clinical trial
simulations and adaptive design methodology)
- Pharmacometrics analysis methodology (e.g. covariate model building =
model qualification)
- Physiology based pharmacokinetics (PBPK) modelling
- Model-informed drug development (MIDD) strategy
- Regulatory strategy for clinical pharmacology and pharmacometric
- Pediatric drug development
- Data programming
- Pharmacometric approaches to analyse discreet data (e.g. time-to-eve=
and count data)
- Mechanism based PK modelling (e.g. enzyme induction/inhibition, targ=
mediated drug disposition and complex absorption)
- Mechanism based model building in therapeutic areas such as;
neuroscience, haematology, diabetes, oncology, inflammation, infectiou=
disease, respiratory disease and many more)
- Translational modelling (e.g. pre-clinical to clinical and adult to
paediatric populations)
- Career advice for junior pharmacometricians
- Pearl-Speaks-NONMEM (PsN) user support. Kajsa Harling, one of the main
developers of PsN, is available to answer your questions.
- R programming and reproducible reporting approaches

If you want to read more about Pharmetheus’ consultants and their
respective competences, please visit our website
Confidentiality agreements (CDA) will be arranged ahead of the meeting for
the discussions that need that. Just make sure to indicate this as you
sign up for a consultancy session on our website Note that if you judge a
confidential disclosure agreement (CDA) is required, this may require some
extra time to put in place ahead of the meeting. The deadline for
applications is the 3rd of June and time slots will be communicated by the
10th of June. Please note that available time slots are limited. Sign =
as soon as possible to give us a chance to help you tackle your

We look forward to hear back from you, and to see you in Stockholm!

The Pharmetheus Team
Pharmetheus AB

+46(0)18 513 328
Uppsala Science Park
Dag Hammarskjölds väg 36b, 2 tr
75237 Uppsala, Sweden
Received on Tue May 21 2019 - 04:36:31 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: